Keyword: MSMB Capital Management
News
09.02.2016
- Martin Shkreli, the 32-year-old former CEO of Turing Pharmaceuticals who made negative headlines last year after jacking up the price of the toxmoplasmosis drug Daraprim...
News
22.12.2015
- Martin Shkreli, CEO of Turing Pharma, which made headlines by raising the price of the 62-year-old drug, Daraprim (pyrimethamine) from $13.50 to $700 a tablet shortly after...
